Adaptive clinical trials use algorithms to predict, during the study, patient outcomes and final study results. These predictions trigger interim decisions, such as early discontinuation of the trial, ...
Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. This is an ASCO Meeting Abstract from the 2025 ...
Revvity, Inc. has unveiled Signals Xynthetica, an AI models-as-a-service platform linking in-silico molecular and materials ...
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Pecan AI, the leader in AI-based predictive analytics for BI analysts and business teams, today announced that it has opened its predictive analytics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results